NCT06988306 Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
| NCT ID | NCT06988306 |
| Status | Recruiting |
| Phase | — |
| Sponsor | California Polytechnic State University-San Luis Obispo |
| Condition | Diabetes Mellitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 978 participants |
| Start Date | 2026-01-15 |
| Primary Completion | 2030-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 978 participants in total. It began in 2026-01-15 with a primary completion date of 2030-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is examining the health effects of gestational diabetes mellitus (GDM) intervention and medically tailored meals within home visiting. A large study is proposed that will include nearly a thousand pregnant or recently pregnant adults with recent GDM and who are from different regions and backgrounds. Two treatment approaches are compared, and both are in home visiting. One treatment group is receiving enhanced lifestyle support for GDM along with meals, and the other is receiving just the enhanced lifestyle support. The study will examine whether these interventions help reduce diabetes and pre-diabetes through 12 months postpartum, as well as other health factors like weight and blood pressure.
Eligibility Criteria
Inclusion Criteria: * Currently in home visiting * Pregnant or \< 3 months (13 weeks) postpartum * Gestational Diabetes Mellitus diagnosis in most recent pregnancy (based on self-report) * Aged 18 years or older * English- or Spanish-speaking. * Not currently being given medically tailored meals * Willing to receive randomization to either group Exclusion Criteria: • Pre-existing diabetes (based on self-report)
Contact & Investigator
Suzanne Phelan, PhD
PRINCIPAL INVESTIGATOR
California Polytechnic State University-San Luis Obispo
Frequently Asked Questions
Who can join the NCT06988306 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06988306 currently recruiting?
Yes, NCT06988306 is actively recruiting participants. Contact the research team at blatzked@calpoly.edu for enrollment information.
Where is the NCT06988306 trial being conducted?
This trial is being conducted at San Luis Obispo, United States, Chicago, United States, Providence, United States.
Who is sponsoring the NCT06988306 clinical trial?
NCT06988306 is sponsored by California Polytechnic State University-San Luis Obispo. The principal investigator is Suzanne Phelan, PhD at California Polytechnic State University-San Luis Obispo. The trial plans to enroll 978 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.